Teladoc Health (NYSE:TDOC) Lowered to Hold at Berenberg Bank

Berenberg Bank cut shares of Teladoc Health (NYSE:TDOCGet Rating) from a buy rating to a hold rating in a research report report published on Tuesday, MarketBeat reports. The firm currently has $35.00 target price on the health services provider’s stock, down from their previous target price of $42.00.

TDOC has been the subject of several other reports. Robert W. Baird lowered their price target on Teladoc Health from $72.00 to $64.00 in a report on Wednesday, April 27th. Cowen downgraded Teladoc Health from an outperform rating to a market perform rating and decreased their price target for the stock from $58.00 to $34.00 in a research note on Tuesday. Piper Sandler decreased their price target on Teladoc Health from $42.00 to $40.00 and set an overweight rating for the company in a research note on Thursday, July 28th. Wells Fargo & Company cut shares of Teladoc Health from an overweight rating to an equal weight rating and cut their target price for the stock from $104.00 to $40.00 in a report on Thursday, April 28th. Finally, Barclays cut their target price on shares of Teladoc Health from $45.00 to $42.00 and set an equal weight rating on the stock in a report on Wednesday, July 20th. One analyst has rated the stock with a sell rating, twenty-three have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of Hold and an average target price of $71.03.

Teladoc Health Trading Up 0.1 %

Shares of Teladoc Health stock opened at $37.48 on Tuesday. Teladoc Health has a fifty-two week low of $27.38 and a fifty-two week high of $156.82. The firm has a market cap of $6.04 billion, a PE ratio of -0.61 and a beta of 0.82. The business’s fifty day moving average is $36.47 and its two-hundred day moving average is $51.88. The company has a quick ratio of 3.71, a current ratio of 3.94 and a debt-to-equity ratio of 0.17.

Insider Transactions at Teladoc Health

In related news, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction dated Friday, June 17th. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following the sale, the senior vice president now owns 28,408 shares of the company’s stock, valued at $827,240.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Mala Murthy sold 4,053 shares of the company’s stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $37.32, for a total value of $151,257.96. Following the sale, the chief financial officer now owns 27,295 shares of the company’s stock, valued at $1,018,649.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the sale, the senior vice president now directly owns 28,408 shares in the company, valued at $827,240.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,053 shares of company stock worth $221,498. 1.55% of the stock is currently owned by company insiders.

Institutional Trading of Teladoc Health

Several large investors have recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System grew its stake in Teladoc Health by 5.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 195,473 shares of the health services provider’s stock worth $6,492,000 after buying an additional 10,583 shares during the last quarter. Landscape Capital Management L.L.C. bought a new stake in Teladoc Health during the second quarter worth about $441,000. Meridian Wealth Management LLC grew its stake in Teladoc Health by 55.0% during the second quarter. Meridian Wealth Management LLC now owns 17,620 shares of the health services provider’s stock worth $585,000 after buying an additional 6,253 shares during the last quarter. Interchange Capital Partners LLC grew its stake in Teladoc Health by 4.4% during the second quarter. Interchange Capital Partners LLC now owns 10,395 shares of the health services provider’s stock worth $345,000 after buying an additional 437 shares during the last quarter. Finally, CMG Global Holdings LLC bought a new stake in Teladoc Health during the second quarter worth about $407,000. 87.17% of the stock is owned by institutional investors.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Stories

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.